An Exploratory Study to Evaluate the Distribution of [111In]ABY-025 Uptake for SPECT Imaging in Subjects With Metastatic Breast Cancer
Phase 1/Phase 2
20 Years
N/A
20 Years
N/A
Not Enrolling
Female
Breast Cancer
Female
Breast Cancer
Trial Information
An Exploratory Study to Evaluate the Distribution of [111In]ABY-025 Uptake for SPECT Imaging in Subjects With Metastatic Breast Cancer
Inclusion Criteria:
- female age >20 years
- one or more known metastases localizations
Exclusion Criteria:
- other critical disease than breast cancer
- age ≤ 20 years
Type of Study:
Interventional
Study Design:
Endpoint Classification: Bio-availability Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Imaging of metastases
Outcome Description:
Imaging of breast cancer metastases using 111-In-ABY015 for SPECT
Outcome Time Frame:
One year
Safety Issue:
Yes
Authority:
Sweden: Medical Products Agency
Study ID:
111InABY025
NCT ID:
NCT01216033
Start Date:
October 2010
Completion Date:
July 2011
Related Keywords:
- Breast Cancer
- Breast cancer
- Diagnostics
- HER2
- Imaging
- Metastases
- SPECT
- Imaging of metastases
- Breast Neoplasms
Name | Location |
|---|
